The rise of Viagra and its impact on the pharmaceutical landscape presents a complex question for investors. While the early sales figures were impressive, the patent has lapsed, leading to a wave of off-brand https://ihannangzu943873.theideasblog.com/41858606/the-blue-pill-and-big-pharma-a-dangerous-opportunity